Chiome Bioscience Inc. (TSE:4583) announced a private placement of 5,567 units of 13th series warrants at ¥4,514 per unit for gross proceeds of ¥25,129,438 on August 30, 2016. Each unit will be exercisable into 1,000 shares at ¥519,000 per unit. The exercise period will be from September 16, 2016 to September 18, 2018. The transaction will take place through third party allotment. The transaction will include participation from Merrill Lynch Japan Securities Co., Ltd., Investment Arm. The allotment date for the transaction is September 15, 2016. The transaction was approved by the board of directors of the company. The company will incur various issue expenses including legal expenses, value calculation expenses, judicial scrivener cost, trust bank expenses, etc.